The BIO-D project has the objective of achieving a better clinical-molecular stratification of patients affected by some pathologies (es. diabetes mellitus, obesity etc.). The partners involved want to identify specific biomarkers that allow the diagnosis of subclasses of patients within any pathology studied by the BIO-D project. The participation of biotechnology companies permits the development of diagnostic tools and the participation of pharmaceutical companies that use SystemsPharmacology permits the identification of active pharmacological molecules adapted to specific patient groups with the same biomolecular pattern. This approach allows greater therapeutic success and creates a synergic interaction between basic research and industrial research. The proposed organizational model is inspired by the “open innovation” strategy where companies use external technological tools and competences from start-ups, universities, research institutes to be competitive. Its goal is to support the emergent systems in the South Italy dedicated to Precision Medicine and Personalized Therapy and help their collaboration with public and private partners coming from the north.
The project is financed by “PON Research and Innovation 2014-2020" and by “Development and Cohesion Fund“.